Showing results (1-10 of 340) with videos related to
Sort By:
Pageof 34
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Topical treatment options for conjunctival neoplasmsJonathan W Kim, David H AbramsonJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 16, 2008
Fibrin sealant for retinoblastoma: where are we?Nancy E Martin, Jonathan W Kim, David H AbramsonDrugs|October 12, 2007
Current management strategies for intraocular retinoblastomaJonathan W Kim, David H Abramson, Ira J DunkelOphthalmic Genetics|January 28, 2009
Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impactDanielle E Novetsky, David H Abramson, Jonathan W Kim, et al.Documenta Ophthalmologica. Advances in Ophthalmology|January 27, 2009
Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastomaScott E Brodie, Y Pierre Gobin, Ira J Dunkel, et al.Ophthalmology|March 18, 2008
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial resultsDavid H Abramson, Ira J Dunkel, Scott E Brodie, et al.Ophthalmic Genetics|April 6, 2022
Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth LectureDavid H AbramsonOphthalmic Genetics|September 4, 2024
What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree LectureDavid H AbramsonOphthalmic Genetics|March 30, 2023
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin LectureDavid H AbramsonPageof 34